Kristina Schultz Tanner, APRN
Family · Athens, GANPI 1558712307
Payments from drug & device makers
Across 87 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$227
- Seagen Inc.$188
- Johnson & Johnson$178
- GSK$146
- Tempus AI, Inc$107
- Novartis$94
- plus $1K from 34 others
What the payments were for
- Food & beverage$1,95191%
- Education$1849%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $227 |
| Seagen Inc. | 6 | $188 |
| Johnson & Johnson | 9 | $178 |
| GSK | 5 | $146 |
| Tempus AI, Inc | 2 | $107 |
| Novartis | 4 | $94 |
| Merck | 5 | $93 |
| Pfizer | 1 | $84 |
| Genentech USA, Inc. | 3 | $67 |
| Karyopharm Therapeutics Inc. | 3 | $60 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $59 |
| Myriad Genetic Laboratories, Inc. | 3 | $56 |
| Stemline Therapeutics Inc. | 2 | $56 |
| Beigene USA, Inc. | 2 | $55 |
| EMD Serono, Inc. | 3 | $47 |
| Rigel Pharmaceuticals, Inc. | 2 | $42 |
| Amgen | 2 | $40 |
| Mirati Therapeutics, Inc. | 2 | $36 |
| Bayer | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Array Biopharma Inc | 2 | $30 |
| Taiho Oncology, Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Tersera Therapeutics LLC | 1 | $28 |
| Delcath Systems | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $26 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Novocure Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Sanofi | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Gilead | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| ADC Therapeutics America, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $17 |
| AbbVie | 1 | $17 |
| Servier Pharmaceuticals LLC | 1 | $16 |
| Exelixis Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TAGRISSO$101
How this compares
$2,135 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Athens
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.